Gilead
Latest News

June 13, 2008 — Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Gilead Sciences
Events
Corporate Responsibility

We are committed to improving the communities in which we live and serve. Our commitment extends beyond the products we offer by demonstrating our compassion and dedication to improving the health of individuals around the world.
Learn more

Gilead Careers and Culture

Our greatest asset is our employees – not only their individual skills, expertise and vision, but their inspired personal commitment to our mission of making a difference in the lives of patients suffering from serious unmet medical needs.
Learn more

Gilead Worldwide

Today, we have more than 3,000 employees and operations in North America and several countries throughout Europe and Australia.
Learn more

Products and Clinical Research
built@zoomedia
Website developed by Zoomedia, Communications for the Life Sciences